{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:05:27Z","timestamp":1784675127125,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ejpn-journal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ejpn.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T05:30:16Z","timestamp":1454131816000},"page":"368-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Safety of levetiracetam among infants younger than 12 months \u2013 Results from a European multicenter observational study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7233-2771","authenticated-orcid":false,"given":"Alexis","family":"Arzimanoglou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"L\u00f6sch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Bentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2016.01.006_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1684\/epd.2007.0144","article-title":"Treatment of pediatric epilepsy: European expert opinion, 2007","volume":"9","author":"Wheless","year":"2007","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.ejpn.2016.01.006_bib2","series-title":"Seizures and syndromes in the first two years of life","first-page":"249","article-title":"Optimizing treatment for n\u00e9onatal and infantile seizures. Do guidelines have a role in management?","author":"Wilmshurst","year":"2013"},{"key":"10.1016\/j.ejpn.2016.01.006_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nurx.2006.01.013","article-title":"New generation anticonvulsants for the treatment of epilepsy in children","volume":"3","author":"Donner","year":"2006","journal-title":"NeuroRx"},{"issue":"Suppl. 1","key":"10.1016\/j.ejpn.2016.01.006_bib4","first-page":"S45","article-title":"Preliminary efficacy of levetiracetam in children","volume":"5","author":"Glauser","year":"2003","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.ejpn.2016.01.006_bib5","series-title":"Seizures and syndromes in the first two years of life","first-page":"71","article-title":"Treatment of neonatal seizures with antiepileptic drugs","author":"Ikonomidou","year":"2013"},{"key":"10.1016\/j.ejpn.2016.01.006_bib6","series-title":"Seizures and syndromes in the first two years of life","first-page":"223","article-title":"Trials for the treatment of infant seizures: theory, practice, ethics and potential future trends","author":"Lux","year":"2013"},{"key":"10.1016\/j.ejpn.2016.01.006_bib7","series-title":"Summary of product characteristics","author":"Keppra (levetiracetam)","year":"2014"},{"key":"10.1016\/j.ejpn.2016.01.006_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1167.2008.01981.x","article-title":"Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures","volume":"50","author":"Pi\u00f1a-Garza","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2016.01.006_bib9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1528-1167.2007.01090.x","article-title":"Pharmacokinetics of levetiracetam in infants and young children with epilepsy","volume":"48","author":"Glauser","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2016.01.006_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.seizure.2005.02.004","article-title":"Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy","volume":"14","author":"Grosso","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2016.01.006_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.seizure.2007.02.004","article-title":"Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy","volume":"16","author":"Grosso","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2016.01.006_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2004.10.004","article-title":"Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial","volume":"14","author":"Lagae","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2016.01.006_bib13","series-title":"Aicardi's epilepsy in children","author":"Arzimanoglou","year":"2004"},{"key":"10.1016\/j.ejpn.2016.01.006_bib14","series-title":"A clinical guide to epileptic syndromes and their treatment","author":"Panayiotopoulous","year":"2010"},{"key":"10.1016\/j.ejpn.2016.01.006_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pediatrneurol.2009.08.002","article-title":"Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy","volume":"42","author":"Lee","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2016.01.006_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pediatrneurol.2007.06.019","article-title":"Levetiracetam monotherapy in newly diagnosed cryptogenic West syndrome","volume":"37","author":"G\u00fcm\u00fc\u015f","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2016.01.006_bib17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0883073807309781","article-title":"Efficacy of levetiracetam in children with epilepsy younger than 2 years of age","author":"Krief","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2016.01.006_bib18","series-title":"Length\/height-for-age, weight-for age, weight-for-length, weight-for-height and body mass index-for-age: methods and development","author":"WHO Child Growth Standards","year":"2006"},{"key":"10.1016\/j.ejpn.2016.01.006_bib19","series-title":"WHO Multicentre Growth Reference Study Group. WHO child growth standards: head circumference-for-age, arm circumference-for-age, triceps skinfold-for-age and subscapular skinfold-for-age: methods and development","author":"WHO Multicentre Growth Reference Study Group","year":"2007"},{"key":"10.1016\/j.ejpn.2016.01.006_bib20","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1528-1167.2007.01201.x","article-title":"Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy","volume":"48","author":"Otoul","year":"2007","journal-title":"Epilepsia"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816000246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816000246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T02:10:32Z","timestamp":1718331032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379816000246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1090379816000246"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2016.01.006","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of levetiracetam among infants younger than 12 months \u2013 Results from a European multicenter observational study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 UCB Biopharma. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}